{"pmid":32473232,"title":"Strengthening early testing and surveillance of COVID-19 to enhance identification of asymptomatic patients.","text":["Strengthening early testing and surveillance of COVID-19 to enhance identification of asymptomatic patients.","J Infect","Wong, Martin Cs","Teoh, Jeremy Yc","Huang, Junjie","Wong, Sunny H","32473232"],"journal":"J Infect","authors":["Wong, Martin Cs","Teoh, Jeremy Yc","Huang, Junjie","Wong, Sunny H"],"date":"2020-05-31T11:00:00Z","year":2020,"_id":"32473232","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1016/j.jinf.2020.05.048","topics":["Prevention"],"weight":1,"_version_":1668255193353945088,"score":9.490897,"similar":[{"pmid":32311142,"title":"Serological tests facilitate identification of asymptomatic SARS-CoV-2 infection in Wuhan, China.","text":["Serological tests facilitate identification of asymptomatic SARS-CoV-2 infection in Wuhan, China.","The Wuhan City has ended the lockdown and people have been allowed to resume working since April 8 if meeting a set of COVID-19-associated tests including SARS-CoV-2 nucleic acid test (NAT) of nasopharyngeal swabs, chest CT scan or a SARS-CoV-2-specific serological test. Here, we reported the positive rate of COVID-19 tests based on NAT, chest CT scan and a serological SARS-CoV-2 test, from April 3 to 15 in one hospital in Qingshan Destrict, Wuhan. We observed a ~10% SARS-CoV-2-specific IgG positive rate from 1,402 tests. Combination of SARS-CoV-2 NAT and a specific serological test might facilitate the detection of COVID-19 infection, or the asymptomatic SARS-CoV-2-infected subjects. Large-scale investigation is required to evaluate the herd immunity of the city, for the resuming people and for the re-opened city. This article is protected by copyright. All rights reserved.","J Med Virol","Wu, Xiaodong","Fu, Bo","Chen, Lang","Feng, Yong","32311142"],"abstract":["The Wuhan City has ended the lockdown and people have been allowed to resume working since April 8 if meeting a set of COVID-19-associated tests including SARS-CoV-2 nucleic acid test (NAT) of nasopharyngeal swabs, chest CT scan or a SARS-CoV-2-specific serological test. Here, we reported the positive rate of COVID-19 tests based on NAT, chest CT scan and a serological SARS-CoV-2 test, from April 3 to 15 in one hospital in Qingshan Destrict, Wuhan. We observed a ~10% SARS-CoV-2-specific IgG positive rate from 1,402 tests. Combination of SARS-CoV-2 NAT and a specific serological test might facilitate the detection of COVID-19 infection, or the asymptomatic SARS-CoV-2-infected subjects. Large-scale investigation is required to evaluate the herd immunity of the city, for the resuming people and for the re-opened city. This article is protected by copyright. All rights reserved."],"journal":"J Med Virol","authors":["Wu, Xiaodong","Fu, Bo","Chen, Lang","Feng, Yong"],"date":"2020-04-21T11:00:00Z","year":2020,"_id":"32311142","source":"PubMed","week":"202017|Apr 20 - Apr 26","doi":"10.1002/jmv.25904","keywords":["coronavirus < virus classification","humoral immunity < immune responses","inapparent infection < epidemiology"],"locations":["Wuhan","Qingshan Destrict","Wuhan","Wuhan","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Diagnosis"],"weight":1,"_version_":1666138491155644416,"score":44.439518}]}